Impact of Aromatherapy on Nausea in Hospitalized Children Undergoing Rehabilitation
Launched by ARKANSAS CHILDREN'S HOSPITAL RESEARCH INSTITUTE · Aug 22, 2023
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Children will participate in the study for two weeks. One week the child will receive a aromatherapy product for nausea and the other week the child will not receive the product.
If this aromatherapy is effective at decreasing nausea, the child may be more likely to participate in their rehabilitation therapy sessions. Information gathered during the study may potentially benefit other patients by helping to develop hospital practices of using aromatherapy in the pediatric rehabilitation unit.
Children participating in the study may or may not help the child but may help children in the f...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients ages 8 to 17 years of age on the rehabilitation unit and service at Arkansas Children's Hospital
- • Patients with a Glascow Coma Scale (GCS) of 13-15
- • Patients with a Rancho Los Amigos Revised Scale score of 5 or higher
- • Ability to read and write in English
- • Patient to have an expected length of stay of at least 2 weeks
- Exclusion Criteria:
- • Patients with any mechanical or obstructive pathophysiology (appendicitis, bowel obstruction, or intussusception, etc.)
- • Known allergy or sensitivity to lavender, peppermint, spearmint, or ginger
- • Patients with known asthma and/or pulmonary conditions
- • Wards of the State or any other agency or institution
About Arkansas Children's Hospital Research Institute
The Arkansas Children's Hospital Research Institute (ACHRI) is a leading pediatric research organization dedicated to advancing child health through innovative scientific inquiry and clinical trials. As an integral part of Arkansas Children's, ACHRI focuses on a wide range of pediatric conditions, aiming to translate research findings into effective therapies and interventions. With a commitment to collaboration, ACHRI partners with academic institutions, healthcare providers, and industry leaders to enhance the understanding of childhood diseases and improve patient outcomes. Their research initiatives are guided by a patient-centered approach, ensuring that the needs and well-being of children remain at the forefront of their efforts.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Little Rock, Arkansas, United States
Patients applied
Trial Officials
Laikin Ulrich, BSN
Principal Investigator
Arkansas Children's Hospital Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported